From Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout:

Corner stone
Corner stone

Image: iStock/Darrin Hughes
https://www.istockphoto.com/portfolio/darrinhughes?assettype=image&mediatype=photography&sort=best